Virtual Symposium: Challenges in Hypertension Management
Thomas Jefferson University’s second annual hypertension symposium will address challenging situations in patients with hypertension, as well as hypertension management in the era of COVID-19.
Over the last decade, hypertension has risen to the number one factor in the global burden of disease. Despite the increased awareness and improved treatment of hypertension, the prevalence of hypertension is rising and controlled rates are stagnant. Medical guidelines aim to steer clinicians toward best practices. The hypertension clinical practice guidelines from the American College of Cardiology (ACC), and the American Heart Association (AHA) raises important questions about hypertension diagnosis and treatment.
The symposium is designed for all healthcare professionals specializing in Family Medicine, Internal Medicine, Cardiology, Nephrology, Neurology, Endocrinology, and Obstetrics. Topics at this year’s event include hypertension and stroke, endocrine hypertension, hypertension and cardio-onco-nephrology, hypertension management during COVID-19: Truths and mistruths, hypertension in diabetes and the role of SGLT2 inhibitors, hypertension and pregnancy. The program features a Keynote Address on Neurogenic Orthostatic Hypotension and Supine Hypertension Pathophysiology Driven Management.
Date: Friday, November 20, 2020
Time: 8:00 a.m. to 1:30 p.m. Eastern Standard Time
Featured at this year’s symposium
|Sentinel information management system||Spacelabs ABP monitoring|